News & Analysis on Clinical Trial Services & Contract Research And Development
ClinTec International and Dr. Reddy's Laboratories have announced a partnership, in which both parties are to jointly develop an anti-cancer drug that belongs to the topoisomerase inhibitors class of compounds.
Scientists have come up with a DNA-based computer, which could lead to faster, more accurate tests for diagnosing West Nile Virus and bird flu more quicker and more accurately.
Researchers have demonstrated that a new compound has the potential to effectively cure epilepsy, raising hopes that a new drug can be produced to treat epileptic patients, who currently have no access to treatment.
Millipore has now made available its GPCRProfiler screening service that allows more accurate characterisation of lead compounds enabling pharmaceutical and biotechnology companies to accelerate their lead optimisation efforts.
UPDATE
Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
Equipment supplier Isopak has launched a new sourcing service to meet the manufacturing needs of its clients.
Paraxel has acquired a $65m (€52m) US business that will inflate its early phase capacity enough to make it one of the largest providers of Phase I services in the world and help "return its US operations to profitability".
Environmental representatives have emerged triumphant in the latest round of negotiations over the finer bones of contention of the European REACH chemicals legislation, due to come in force in April next year.
LifeCycle has signed three collaboration agreements with big pharma companies for the development of new anti-cholesterol products using its novel drug delivery technologies.